Axa S.A. Sells 3,393 Shares of The Cigna Group (NYSE:CI)

AXA S.A. lessened its holdings in shares of The Cigna Group (NYSE:CI - Free Report) by 2.3% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 142,171 shares of the health services provider's stock after selling 3,393 shares during the quarter. AXA S.A. owned approximately 0.05% of The Cigna Group worth $39,259,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. TCTC Holdings LLC acquired a new stake in shares of The Cigna Group during the 4th quarter worth approximately $25,000. Collier Financial acquired a new stake in The Cigna Group during the fourth quarter worth $32,000. ORG Wealth Partners LLC bought a new stake in The Cigna Group in the 4th quarter valued at $34,000. Compagnie Lombard Odier SCmA bought a new position in shares of The Cigna Group during the 4th quarter worth about $37,000. Finally, Transce3nd LLC acquired a new stake in shares of The Cigna Group during the 4th quarter valued at about $38,000. 86.99% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at The Cigna Group

In other The Cigna Group news, Director Elder Granger sold 2,376 shares of the business's stock in a transaction dated Friday, March 14th. The shares were sold at an average price of $310.35, for a total transaction of $737,391.60. Following the sale, the director now directly owns 5,471 shares of the company's stock, valued at $1,697,924.85. The trade was a 30.28 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. Also, CEO David Cordani sold 26,527 shares of the company's stock in a transaction dated Monday, March 3rd. The stock was sold at an average price of $308.12, for a total value of $8,173,499.24. Following the sale, the chief executive officer now owns 127,767 shares in the company, valued at $39,367,568.04. The trade was a 17.19 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 43,751 shares of company stock worth $13,603,991 in the last quarter. Corporate insiders own 0.70% of the company's stock.

Wall Street Analyst Weigh In

A number of research analysts have commented on the stock. UBS Group cut their price target on shares of The Cigna Group from $410.00 to $390.00 and set a "buy" rating for the company in a research note on Monday, February 3rd. Piper Sandler upped their price target on The Cigna Group from $348.00 to $374.00 and gave the company an "overweight" rating in a research report on Monday. Oppenheimer reduced their target price on shares of The Cigna Group from $400.00 to $375.00 and set an "outperform" rating on the stock in a research note on Friday, January 31st. Royal Bank of Canada set a $355.00 target price on shares of The Cigna Group in a research report on Friday, January 31st. Finally, Cantor Fitzgerald raised their price objective on shares of The Cigna Group from $350.00 to $365.00 and gave the stock an "overweight" rating in a report on Thursday, March 20th. Two investment analysts have rated the stock with a hold rating, fifteen have issued a buy rating and three have issued a strong buy rating to the company's stock. According to data from MarketBeat, the company has an average rating of "Buy" and an average target price of $378.22.

The Cigna Group Trading Up 0.3 %

CI stock traded up $1.00 during midday trading on Tuesday, reaching $334.01. The company's stock had a trading volume of 1,825,726 shares, compared to its average volume of 1,700,114. The company has a quick ratio of 0.72, a current ratio of 0.66 and a debt-to-equity ratio of 0.70. The Cigna Group has a 52 week low of $262.03 and a 52 week high of $370.83. The business's 50-day simple moving average is $323.77 and its 200-day simple moving average is $309.57. The stock has a market cap of $91.41 billion, a PE ratio of 27.29, a price-to-earnings-growth ratio of 0.98 and a beta of 0.47.

The Cigna Group (NYSE:CI - Get Free Report) last posted its earnings results on Friday, May 2nd. The health services provider reported $6.74 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.35 by $0.39. The company had revenue of $65.45 billion during the quarter, compared to analyst estimates of $60.39 billion. The Cigna Group had a return on equity of 18.61% and a net margin of 1.39%. The company's revenue for the quarter was up 14.4% compared to the same quarter last year. During the same period in the previous year, the company earned $6.47 EPS. As a group, sell-side analysts expect that The Cigna Group will post 29.77 EPS for the current year.

The Cigna Group Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, June 18th. Stockholders of record on Tuesday, June 3rd will be given a dividend of $1.51 per share. The ex-dividend date of this dividend is Tuesday, June 3rd. This represents a $6.04 dividend on an annualized basis and a dividend yield of 1.81%. The Cigna Group's dividend payout ratio is 49.35%.

The Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.